PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
3.75%
Revenue growth below 50% of CRWV's 23.55%. Michael Burry would check for competitive disadvantage risks.
5.34%
Cost growth less than half of CRWV's 19.16%. David Dodd would verify if cost advantage is structural.
3.28%
Gross profit growth below 50% of CRWV's 25.15%. Michael Burry would check for structural issues.
-0.45%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
3.06%
R&D change of 3.06% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
-1.22%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
10.75%
Marketing expense growth less than half of CRWV's 248.84%. David Dodd would verify if efficiency advantage is sustainable.
935.00%
Other expenses growth above 1.5x CRWV's 19.33%. Michael Burry would check for concerning trends.
6.07%
Operating expenses growth less than half of CRWV's 17.97%. David Dodd would verify sustainability.
5.81%
Total costs growth less than half of CRWV's 18.28%. David Dodd would verify sustainability.
-100.00%
Interest expense reduction while CRWV shows 1.19% growth. Joel Greenblatt would examine advantage.
4.05%
D&A growth less than half of CRWV's 26.15%. David Dodd would verify if efficiency is sustainable.
-74.07%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
1.80%
EBITDA margin growth below 50% of CRWV's 7.69%. Michael Burry would check for structural issues.
-96.99%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-97.10%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
1618.18%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
-94.36%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-94.56%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-32.19%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-109.63%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-109.28%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-109.62%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-109.78%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-0.15%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-1.29%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.